ExecutiveGov – The departments of Veterans Affairs and Energy have partnered to analyze big data from the VA and other federal sources as they optimize healthcare for veterans and other citizens.
In today's Genetics / Genomics SciPol Daily, using DNA to identify sailors who died looking for the Northwest Passage in 1845; California's stem cell agency running low on money; and a DNA-based "liquid biopsy" to find cancer earlier than before.
In today's Nanotechnology SciPol Daily, a tactile sensor to serve as robot "skin"; using graphene nanoribbons to weigh individual proteins; imaging electric currents flowing through graphene; and a nanomedicine drug for pancreatic cancer.
Phys.org – Researchers have developed biodegradable nanoparticles that can be used to genetically program immune cells to recognize and destroy cancer cells—while the immune cells are still inside the body.
GenomeWeb – Genetic counselors in the cancer field experienced changes to their practice soon after a Supreme Court ruling that effectively expanded the types of genetic tests available for assessing individuals' risk of hereditary breast and ovarian cancer (HBOC), results from a recently published survey suggest.
Phys.org – Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types.
MIT Technology Review – Google knows all about your habits and interests online. Now the search company’s health spinout, Verily, is asking 10,000 Americans for intimate knowledge of their bodies.
In today's Nanotechnology SciPol Daily, nanoparticle immunotherapy to treat cancer; attention toward geoengineering; investigating therapeutic nanomaterials; and using pressure rather than chemistry to build nanowire arrays.
The Engineer – Researchers have found that using nanoparticles can boost the efficacy of cancer immunotherapy treatments.
University of Alabama Birmingham – Chemists have designed triple-threat cancer-fighting polymer capsules that bring the promise of guided drug delivery closer to preclinical testing.
The Conversation – There is more to cancer and other diseases than our genes. In addition to the DNA code, there is a hidden layer of regulation controlling the activity of genes – while not changing the DNA itself. This is epigenetics.
Nature – Some scientists are advocating that researchers shift their focus back in time: to study the DNA of tumours in their adolescence, before they commit to being cancerous.